vs

Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

CSW INDUSTRIALS, INC. is the larger business by last-quarter revenue ($233.0M vs $208.9M, roughly 1.1× iRhythm Holdings, Inc.). CSW INDUSTRIALS, INC. runs the higher net margin — 4.4% vs 2.7%, a 1.7% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 20.3%). CSW INDUSTRIALS, INC. produced more free cash flow last quarter ($22.7M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 5.1%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

CSW vs IRTC — Head-to-Head

Bigger by revenue
CSW
CSW
1.1× larger
CSW
$233.0M
$208.9M
IRTC
Growing faster (revenue YoY)
IRTC
IRTC
+6.8% gap
IRTC
27.1%
20.3%
CSW
Higher net margin
CSW
CSW
1.7% more per $
CSW
4.4%
2.7%
IRTC
More free cash flow
CSW
CSW
$8.2M more FCF
CSW
$22.7M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
5.1%
CSW

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CSW
CSW
IRTC
IRTC
Revenue
$233.0M
$208.9M
Net Profit
$10.3M
$5.6M
Gross Margin
39.7%
70.9%
Operating Margin
7.4%
1.1%
Net Margin
4.4%
2.7%
Revenue YoY
20.3%
27.1%
Net Profit YoY
-61.9%
518.5%
EPS (diluted)
$0.62
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSW
CSW
IRTC
IRTC
Q4 25
$233.0M
$208.9M
Q3 25
$277.0M
$192.9M
Q2 25
$263.6M
$186.7M
Q1 25
$230.5M
$158.7M
Q4 24
$193.6M
$164.3M
Q3 24
$227.9M
$147.5M
Q2 24
$226.2M
$148.0M
Q1 24
$210.9M
$131.9M
Net Profit
CSW
CSW
IRTC
IRTC
Q4 25
$10.3M
$5.6M
Q3 25
$40.7M
$-5.2M
Q2 25
$40.9M
$-14.2M
Q1 25
$35.1M
$-30.7M
Q4 24
$26.9M
$-1.3M
Q3 24
$36.1M
$-46.2M
Q2 24
$38.6M
$-20.1M
Q1 24
$31.8M
$-45.7M
Gross Margin
CSW
CSW
IRTC
IRTC
Q4 25
39.7%
70.9%
Q3 25
43.0%
71.1%
Q2 25
43.8%
71.2%
Q1 25
44.2%
68.8%
Q4 24
41.4%
70.0%
Q3 24
45.6%
68.8%
Q2 24
47.5%
69.9%
Q1 24
44.4%
66.3%
Operating Margin
CSW
CSW
IRTC
IRTC
Q4 25
7.4%
1.1%
Q3 25
20.5%
-4.4%
Q2 25
20.8%
-10.0%
Q1 25
19.5%
-20.5%
Q4 24
15.3%
-2.5%
Q3 24
22.6%
-34.1%
Q2 24
24.3%
-15.5%
Q1 24
21.0%
-28.9%
Net Margin
CSW
CSW
IRTC
IRTC
Q4 25
4.4%
2.7%
Q3 25
14.7%
-2.7%
Q2 25
15.5%
-7.6%
Q1 25
15.2%
-19.3%
Q4 24
13.9%
-0.8%
Q3 24
15.8%
-31.3%
Q2 24
17.1%
-13.6%
Q1 24
15.1%
-34.6%
EPS (diluted)
CSW
CSW
IRTC
IRTC
Q4 25
$0.62
$0.18
Q3 25
$2.41
$-0.16
Q2 25
$2.43
$-0.44
Q1 25
$2.05
$-0.97
Q4 24
$1.60
$-0.03
Q3 24
$2.26
$-1.48
Q2 24
$2.47
$-0.65
Q1 24
$2.03
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSW
CSW
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$40.2M
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$152.7M
Total Assets
$2.3B
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSW
CSW
IRTC
IRTC
Q4 25
$40.2M
$583.8M
Q3 25
$31.5M
$565.2M
Q2 25
$38.0M
$545.5M
Q1 25
$225.8M
$520.6M
Q4 24
$213.8M
$535.6M
Q3 24
$273.2M
$522.0M
Q2 24
$18.9M
$561.5M
Q1 24
$22.2M
$569.1M
Total Debt
CSW
CSW
IRTC
IRTC
Q4 25
Q3 25
Q2 25
Q1 25
$800.1M
Q4 24
Q3 24
Q2 24
Q1 24
$166.0M
Stockholders' Equity
CSW
CSW
IRTC
IRTC
Q4 25
$1.1B
$152.7M
Q3 25
$1.1B
$121.9M
Q2 25
$1.1B
$103.7M
Q1 25
$1.1B
$86.7M
Q4 24
$1.0B
$90.9M
Q3 24
$1.0B
$71.8M
Q2 24
$650.2M
$99.2M
Q1 24
$615.7M
$90.3M
Total Assets
CSW
CSW
IRTC
IRTC
Q4 25
$2.3B
$1.0B
Q3 25
$1.5B
$995.2M
Q2 25
$1.5B
$964.0M
Q1 25
$1.4B
$926.1M
Q4 24
$1.4B
$931.4M
Q3 24
$1.4B
$909.7M
Q2 24
$1.1B
$919.2M
Q1 24
$1.0B
$909.8M
Debt / Equity
CSW
CSW
IRTC
IRTC
Q4 25
Q3 25
Q2 25
Q1 25
0.75×
Q4 24
Q3 24
Q2 24
Q1 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSW
CSW
IRTC
IRTC
Operating Cash FlowLast quarter
$28.9M
$26.2M
Free Cash FlowOCF − Capex
$22.7M
$14.5M
FCF MarginFCF / Revenue
9.8%
6.9%
Capex IntensityCapex / Revenue
2.6%
5.6%
Cash ConversionOCF / Net Profit
2.81×
4.70×
TTM Free Cash FlowTrailing 4 quarters
$162.0M
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSW
CSW
IRTC
IRTC
Q4 25
$28.9M
$26.2M
Q3 25
$61.8M
$34.9M
Q2 25
$60.6M
$27.7M
Q1 25
$27.3M
$-7.9M
Q4 24
$11.6M
$19.2M
Q3 24
$66.8M
$24.3M
Q2 24
$62.7M
$11.8M
Q1 24
$22.4M
$-52.0M
Free Cash Flow
CSW
CSW
IRTC
IRTC
Q4 25
$22.7M
$14.5M
Q3 25
$58.7M
$20.1M
Q2 25
$57.7M
$17.3M
Q1 25
$22.8M
$-17.3M
Q4 24
$8.5M
$12.4M
Q3 24
$61.3M
$15.5M
Q2 24
$59.6M
$3.4M
Q1 24
$17.5M
$-61.8M
FCF Margin
CSW
CSW
IRTC
IRTC
Q4 25
9.8%
6.9%
Q3 25
21.2%
10.4%
Q2 25
21.9%
9.3%
Q1 25
9.9%
-10.9%
Q4 24
4.4%
7.5%
Q3 24
26.9%
10.5%
Q2 24
26.3%
2.3%
Q1 24
8.3%
-46.8%
Capex Intensity
CSW
CSW
IRTC
IRTC
Q4 25
2.6%
5.6%
Q3 25
1.1%
7.7%
Q2 25
1.1%
5.6%
Q1 25
2.0%
5.9%
Q4 24
1.6%
4.2%
Q3 24
2.4%
6.0%
Q2 24
1.4%
5.7%
Q1 24
2.3%
7.4%
Cash Conversion
CSW
CSW
IRTC
IRTC
Q4 25
2.81×
4.70×
Q3 25
1.52×
Q2 25
1.48×
Q1 25
0.78×
Q4 24
0.43×
Q3 24
1.85×
Q2 24
1.62×
Q1 24
0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSW
CSW

Contractor Solutions Segment$166.3M71%
Specialized Reliability Solutions Segment$38.2M16%
Engineered Building Solutions Segment$28.5M12%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons